Click Therapeutics raised $52 million in a Series B funding round

What is Click Therapeutics?

Click Therapeutics is a regulated Software as a Medical Device (SaMD)-focused biotechnology company.

What does Click Therapeutics do?

The company develops software as prescription medical treatments for people with unmet medical needs. Click’s Digital TherapeuticsTM promotes change within individuals through cognitive and neurobehavioral mechanisms and is designed to be utilized independently or in conjunction with biological treatments.

Who owns Click Therapeutics?

David Benshoof Klein and Victor Gao launched the company at the beginning of 2012, with headquarters in New York.

How much has Click Therapeutics raised?

Click Therapeutics has raised a total of $911 million, with the most recent funding being $52 million in a Series B round.

Who has invested in Click Therapeutics?

Fourteen investors have put their money into Click Therapeutics. The most recent investors are Hikma Ventures and Revelation Partners.

What domain name does Click Therapeutics operate on?

Click Therapeutics operates on the exact brand match domain ClickTherapeutics.com. This ensures their brand is well protected online, avoids traffic and email leaks as well as confusion amongst their customers and business partners.

Latest on Twitter

SB RSS